In The News
Oranges and lemons can help STOP diseases caused by obesity including diabetes
Oranges and lemons can help STOP diseases caused by obesity including diabetes ORANGES and lemons not only pack a vitamin C punch to keep a cold at bay, they can hep prevent obesity-related heart disease, liver disease and diabetes. By KATRINA TURRILL PUBLISHED: 14:04, Sun, Aug 21, 2016 | UPDATED: 14:14, Sun, Aug 21, 2016…
Read MoreResults of Phase 3 POISE Trial of Ocaliva® (Obeticholic Acid) for the Treatment of PBC
NEW YORK, Aug. 17, 2016 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, today announced that the New England Journal of Medicine published the key results of the Phase 3 POISE trial of Ocaliva (obeticholic acid) for the treatment…
Read MoreWho Is Getting Hep C Treatment?
The Hepatitis C virus causes progressive liver damage and is the leading cause of liver transplants in the U.S., yet its gravity is frequently disregarded. According to the U.S. Centers for Disease Control and Prevention, more people die from Hepatitis C than from 60 other infectious diseases combined. Despite major advances in Hepatitis C treatment,…
Read MoreSue Bennett going for Gold at the Transplant Games.
Some inspiration for all of us….Sue Bennett going for Gold at the Transplant Games. Transplant Games: Going for gold as a gift to a donor… Transplant Games: Going for gold as a gift to a donor… from Emma Thomas on Vimeo.
Read MoreThe Drug Costs $95K. Its Maker 'Dodged' $10B in Taxes
A pharmaceutical company that has in recent years made billions of dollars on hepatitis C treatments—the three the FDA has approved range from $75,000 to $94,500—has been named a “price gouger” and “tax dodger” in a new report. Gilead Sciences, the sixth richest drugmaker in the world, “is making a fortune selling essential drugs to…
Read MoreFDA approves first pill to treat all forms of hepatitis C
Federal health officials on Tuesday approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus. The Food and Drug Administration approved the combination pill, Epclusa, from Gilead Sciences, for patients with and without liver damage. The new…
Read MoreNow There Are Many (Stages)
Now There Are Many (Stages) Where Before There Was One: In Search of a Pathophysiological Classification of Cirrhosis Guadalupe Garcia-Tsao,1 Scott Friedman,2 John Iredale,3 and Massimo Pinzani4 For more than a century and a half, the description of a liver as “cirrhotic” was sufficient to connote both a pathological and clinical status, and to assign…
Read MoreHow coffee could be your liver's savior
How coffee could be your liver’s savior: Drink shown to protect against a host of deadly diseases Drink may protect against certain cancers that affect the womb and liver World Health Organisation says no link between coffee and bladder cancer New research concludes that coffee protects against fatty liver disease, liver fibrosis and liver cirrhosis…
Read MoreFederal Standard May Be Thwarting Some Liver Transplant Patients
Federal Standard May Be Thwarting Some Liver Transplant Patients By EDITOR • JUN 7, 2016 Did revised federal standards make transplant centers more averse to risk and encourage them to drop sicker patients who might affect the hospitals’ patient survival rates? Originally published on June 9, 2016 4:47 pm For the roughly 15,000 people who…
Read MoreChanges to MELD score to include serum sodium
(Confusing at first glance but the numbers in the squares show how much your current meld score will go up dependent upon your serum sodium value.) Effective Date Jan 11 2016 NOV 16, 2015 | LIVER/INTESTINE, TRANSPLANT CENTER New Resources Available for Liver Transplant Programs On January 11, 2016, OPTN Policy 9.1 (MELD Score) will…
Read More